Clinical trial · Observational
Pattern of Treatment and Outcomes of Locally Advanced Rectal Carcinoma
Pattern of Treatment and Outcomes of Locally Advanced Rectal Carcinoma : a Retrospective Study
NCT07363863CI-TRIAL-00101580not yet recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
the study will discuss different pattern of treatment and the outcomes of locally advanced rectal carcinoma as a retrospective study. The study will be conducted at Department of Clinical Oncology, Sohag University Hospital and Sohag Cancer center, Sohag, Egypt. including patients diagnosed and treated between 2018 and 2025. and the data will be collected from reports .
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Rectal Carcinoma | Rectal Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| No Intervention (subjects were previously treated with Onglyza®) | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (3)
- measure
- Estimation of overall survival (OS ).
- timeFrame
- 2018 _ 2025
- measure
- Estimation of Response rate .
- timeFrame
- 2018-2025
- measure
- Estimation of disease-free survival (DFS) .
- timeFrame
- 2018-2025
Secondary outcomes (1)
- measure
- treatment-related toxicity: (graded by CTCAE v5).
- timeFrame
- 2018-2025
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * patients who were more than18 years old at time of diagnosis. * Patients with histologically confirmed rectal carcinoma. * Stage II-III (locally advanced) disease at initial diagnosis. Exclusion Criteria: * Patients with distant metastasis at presentation. * Patients diagnosed with double malignancy. * Patients with incomplete medical records. * Organ failure
References
Publications (0)
Data not yet available
No reference posted for this study.